Anne V. Philips

4.8k total citations · 3 hit papers
28 papers, 3.6k citations indexed

About

Anne V. Philips is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Anne V. Philips has authored 28 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Anne V. Philips's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Anne V. Philips is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Anne V. Philips collaborates with scholars based in United States, Australia and Türkiye. Anne V. Philips's co-authors include Thomas A. Cooper, Rajesh S. Savkur, Lubov Timchenko, Thomas Cooper, Elizabeth A. Mittendorf, Gheath Alatrash, Gopal K. Singh, Jeffrey J. Molldrem, Nicolas Charlet‐Berguerand and Elizabeth A. Grice and has published in prestigious journals such as Science, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Anne V. Philips

28 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-L1 Expression in Triple-Negative Breast Cancer

2014 1.1k citations Elizabeth A. Mittendorf, Anne V. Philips et al. Cancer Immunology Research profile →
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy

1998 668 citations Anne V. Philips, Thomas A. Cooper et al. profile →
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy

2001 630 citations Rajesh S. Savkur, Anne V. Philips et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne V. Philips United States	16	2.2k	1.3k	1.2k	675	356	28	3.6k
Dara Kallop United States	13	1.2k 0.5×	278 0.2×	579 0.5×	427 0.6×	78 0.2×	13	2.1k
Geraldine Mbamalu Canada	17	2.9k 1.3×	706 0.5×	663 0.6×	360 0.5×	43 0.1×	20	4.0k
Richard A. Klinghoffer United States	18	1.7k 0.8×	327 0.2×	418 0.4×	280 0.4×	58 0.2×	31	2.5k
Kurtis D. Davies United States	24	1.3k 0.6×	295 0.2×	969 0.8×	634 0.9×	27 0.1×	51	2.9k
Vladimir Lhotak Canada	5	2.1k 0.9×	574 0.4×	246 0.2×	292 0.4×	98 0.3×	6	2.8k
Naohiko Ikegaki United States	35	2.6k 1.2×	593 0.4×	765 0.7×	343 0.5×	24 0.1×	91	3.8k
Kazuhiro Ogi Japan	27	1.4k 0.6×	349 0.3×	612 0.5×	186 0.3×	67 0.2×	74	2.3k
Diana Graus-Porta Switzerland	18	2.2k 1.0×	494 0.4×	2.4k 2.0×	236 0.3×	30 0.1×	18	4.1k
Saïd Akli United States	24	1.0k 0.5×	287 0.2×	509 0.4×	123 0.2×	51 0.1×	40	1.8k
Chris Shelley United States	22	953 0.4×	281 0.2×	266 0.2×	315 0.5×	116 0.3×	39	1.7k

Countries citing papers authored by Anne V. Philips

Since Specialization

Citations

This map shows the geographic impact of Anne V. Philips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne V. Philips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne V. Philips more than expected).

Fields of papers citing papers by Anne V. Philips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne V. Philips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne V. Philips. The network helps show where Anne V. Philips may publish in the future.

Co-authorship network of co-authors of Anne V. Philips

This figure shows the co-authorship network connecting the top 25 collaborators of Anne V. Philips. A scholar is included among the top collaborators of Anne V. Philips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne V. Philips. Anne V. Philips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldberg, Jonathan, Jennifer L. Guerriero, Anne V. Philips, et al.. (2024). Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer. Cancer Research Communications. 4(2). 496–504. 7 indexed citations

Shi, Chunhua, Jun Yan, Mao Zhang, et al.. (2023). AML Immunotherapy Using a Novel Tcrm-Based Bispecific Antibody That Targets a Leader Sequence Peptide Derived from Cathepsin G. Blood. 142(Supplement 1). 1415–1415. 1 indexed citations

Chick, Robert C., Guy T. Clifton, Diane F. Hale, et al.. (2021). Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer. Clinical Immunology. 225. 108679–108679. 34 indexed citations

Sukhumalchandra, Pariya, Anne V. Philips, Na Qiao, et al.. (2021). Pembrolizumab in Combination with Antigen-Specific Cytotoxic T Lymphocytes Enhances Killing of Acute Myeloid Leukemia. Blood. 138(Supplement 1). 2775–2775. 1 indexed citations

Clifton, Guy T., Diane F. Hale, Timothy J. Vreeland, et al.. (2020). Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer. Clinical Cancer Research. 26(11). 2515–2523. 75 indexed citations

Alatrash, Gheath, Na Qiao, Pariya Sukhumalchandra, et al.. (2019). Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes. Clinical Cancer Research. 25(8). 2610–2620. 21 indexed citations

Khan, Maliha, Pariya Sukhumalchandra, Jason Roszik, et al.. (2018). Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target. Frontiers in Immunology. 8. 1975–1975. 20 indexed citations

Vreeland, Timothy J., Jennifer K. Litton, Na Qiao, et al.. (2018). Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39’: An analysis of safety and immune response. Clinical Immunology. 192. 6–13. 8 indexed citations

Philips, Anne V., Na Qiao, Karen Clise-Dwyer, et al.. (2017). Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells. Cancer Research. 77(19). 5374–5383. 124 indexed citations

10.

Chawla, Akhil, Gheath Alatrash, Anne V. Philips, et al.. (2016). Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells. Cancer Immunology Immunotherapy. 65(6). 741–751. 19 indexed citations

11.

Mittendorf, Elizabeth A., Anne V. Philips, Funda Meric‐Bernstam, et al.. (2014). PD-L1 Expression in Triple-Negative Breast Cancer. Cancer Immunology Research. 2(4). 361–370. 1065 indexed citations breakdown →

12.

Chawla, Akhil, Anne V. Philips, Gheath Alatrash, & Elizabeth A. Mittendorf. (2014). Immune checkpoints. OncoImmunology. 3(4). e28325–e28325. 31 indexed citations

13.

Mittendorf, Elizabeth A., Gheath Alatrash, Na Qiao, et al.. (2012). Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response. Cancer Research. 72(13). 3153–3162. 72 indexed citations

14.

Savkur, Rajesh S., Anne V. Philips, Thomas A. Cooper, et al.. (2004). Insulin Receptor Splicing Alteration in Myotonic Dystrophy Type 2. The American Journal of Human Genetics. 74(6). 1309–1313. 123 indexed citations

15.

Griffiths, Anthony D., et al.. (2003). Harvest of Bombax ceiba for the Aboriginal arts industry, central Arnhem Land, Australia. Biological Conservation. 113(2). 295–305. 32 indexed citations

16.

Charlet‐Berguerand, Nicolas, Rajesh S. Savkur, Gopal K. Singh, et al.. (2002). Loss of the Muscle-Specific Chloride Channel in Type 1 Myotonic Dystrophy Due to Misregulated Alternative Splicing. Molecular Cell. 10(1). 45–53. 482 indexed citations

17.

Savkur, Rajesh S., Anne V. Philips, & Thomas A. Cooper. (2001). Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nature Genetics. 29(1). 40–47. 630 indexed citations breakdown →

18.

Philips, Anne V. & Thomas Cooper. (2000). RNA processing and human disease. Cellular and Molecular Life Sciences. 57(2). 235–249. 114 indexed citations

19.

Yang, Baoli, et al.. (1994). Initiation of Transcription at the Human Terminal Deoxynucleotidyl Transferase Gene Promoter: A Novel Role for the TATA Binding Protein. Biochemistry. 33(36). 11025–11032. 6 indexed citations

20.

Philips, Anne V., Mary Sue Colemán, Karol Maskos, & Mary D. Barkley. (1989). Time-resolved fluorescence spectroscopy of human adenosine deaminase: effects of enzyme inhibitors on protein conformation. Biochemistry. 28(5). 2040–2050. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact